Neurogeneticist Matthew DeGennaro is the first scientist to make a mutant mosquito — a game-changing tool in researching ...

The end point of this double-blind ... 1999;82(suppl 4):IV14 IV22. Altered adrenergic receptor sensitivity due to polymorphic variation. Arg389=arginine; Gly389=glycine. Adapted from J Biol ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

In early December 2024, a group of researchers published an article in the journal Science, entitled "A single mutation in ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to ...

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...

Sage Therapeutics' financials indicate a need for additional funding in 2025, risking dilution and further financial ...

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

Depression continues to grapple a large proportion of the population. Given the side effects associated with the long-term use of conventional antidepressants, there is a need for novel rapid acting ...

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for ...

The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...